International Patent: SIMPINICLINE ORAL FORMULATIONS AND USE THEREOF

GENEVA, July 1 -- OYSTER POINT PHARMA, INC. filed a patent application (US2025/049985) for “SIMPINICLINE ORAL FORMULATIONS AND USE THEREOF”. With publication no. WO/2026/080563, here are the other details related to the patent application:

Kind: Correction of entry in Section I of the PCT Gazette [A8]

IPC: A61K 9/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....